The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology

Journal of Biological Chemistry

Volumn 288, Issue 12, 2013, Pages 8176-8186

  Harris, Nicole C ^a,b   Davydova, Natalia ^a   Roufail, Sally ^a   Paquet Fifield, Sophie ^a   Paavonen, Karri ^b   Karnezis, Tara ^a   Zhang, You Fang ^a   Sato, Teruhiko ^a   Rothacker, Julie ^b   Nice, Edouard C ^b   Stacker, Steven A ^a,b,c   Achen, Marc G ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLANTS (BOTANY); POLYSACCHARIDES; TUMORS;

ANGIOGENIC SPROUTING; BIOLOGICAL FUNCTIONS; C-TERMINAL PROPEPTIDE; HEPARIN BINDING; HETERODIMERIZATION; HOMOLOGY DOMAIN; LYMPH NODE METASTASIS; TUMOR BIOLOGY;

BINDING SITES;

AMINO TERMINAL PROPEPTIDE; CARBOXY TERMINAL PROPEPTIDE; HEPARIN; HETERODIMER; PEPTIDE; PROPEPTIDE; UNCLASSIFIED DRUG; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIMERIZATION; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN DOMAIN; TUMOR GROWTH; TUMOR PROMOTION; TUMOR VASCULARIZATION;

EID: 84875459759     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.439299     Document Type: Article

References (56)

1. Tammela, T., and Alitalo, K. (2010) Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140, 460-476
2. Achen, M. G., McColl, B. K., and Stacker, S. A. (2005) Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7, 121-127 (Pubitemid 40248338)
3. Potente, M., Gerhardt, H., and Carmeliet, P. (2011) Basic and therapeutic aspects of angiogenesis. Cell 146, 873-887
4. Seyama, K., Kumasaka, T., Kurihara, M., Mitani, K., and Sato, T. (2010) Lymphangioleiomyomatosis: a disease involving the lymphatic system. Lymphat. Res. Biol. 8, 21-31
5. Achen, M. G., Jeltsch, M., Kukk, E., Mäkinen, T., Vitali, A., Wilks, A. F., Alitalo, K., and Stacker, S. A. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. U.S.A. 95, 548-553 (Pubitemid 28083780)
6. Bhardwaj, S., Roy, H., Gruchala, M., Viita, H., Kholova, I., Kokina, I., Achen, M. G., Stacker, S. A., Hedman, M., Alitalo, K., and Ylä-Herttuala, S. (2003) Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. Hum. Gene Ther. 14, 1451-1562
7. Wise, L. M., Ueda, N., Dryden, N. H., Fleming, S. B., Caesar, C., Roufail, S., Achen, M. G., Stacker, S. A., and Mercer, A. A. (2003) Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor- binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J. Biol. Chem. 278, 38004-38014 (Pubitemid 37175331)
8. Rutanen, J., Rissanen, T. T., Markkanen, J. E., Gruchala, M., Silvennoinen, P., Kivelä, A., Hedman, A., Hedman, M., Heikura, T., Ordén, M. R., Stacker, S. A., Achen, M. G., Hartikainen, J., and Ylä-Herttuala, S. (2004) Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109, 1029-1035 (Pubitemid 38282857)
9. Rissanen, T. T., Markkanen, J. E., Gruchala, M., Heikura, T., Puranen, A., Kettunen, M. I., Kholová, I., Kauppinen, R. A., Achen, M. G., Stacker, S. A., Alitalo, K., and Ylä-Herttuala, S. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92, 1098-1106 (Pubitemid 36665855)
10. Haiko, P., Makinen, T., Keskitalo, S., Taipale, J., Karkkainen, M. J., Baldwin, M. E., Stacker, S. A., Achen, M. G., and Alitalo, K. (2008) Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol. Cell. Biol. 28, 4843-4850
11. Baldwin, M. E., Stacker, S. A., and Achen, M. G. (2002) Molecular control of lymphangiogenesis. Bioessays 24, 1030-1040 (Pubitemid 35326161)
12. Achen, M. G., Stacker, S.A. (2012) Vascular endothelial growth factor-D: signalling mechanisms, biology and clinical relevance. Growth Factors 30, 283-296
13. Stacker, S. A., Caesar, C., Baldwin, M. E., Thornton, G. E., Williams, R. A., Prevo, R., Jackson, D. G., Nishikawa, S., Kubo, H., and Achen, M. G. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nature Med. 7, 186-191 (Pubitemid 32148485)
14. Kopfstein, L., Veikkola, T., Djonov, V. G., Baeriswyl, V., Schomber, T., Strittmatter, K., Stacker, S. A., Achen, M. G., Alitalo, K., and Christofori, G. (2007) Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am. J. Pathol. 170, 1348-1361 (Pubitemid 47339341)
15. Shayan, R., Achen, M. G., and Stacker, S. A. (2006) Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27, 1729-1738 (Pubitemid 44307827)
16. Karnezis, T., Shayan, R., Caesar, C., Roufail, S., Harris, N. C., Ardipradja, K., Zhang, Y. F., Williams, S. P., Farnsworth, R. H., Chai, M. G., Rupasinghe, T. W., Tull, D. L., Baldwin, M. E., Sloan, E. K., Fox, S. B., Achen, M. G., and Stacker, S. A. (2012) VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21, 181-195
17. Debinski, W., Slagle-Webb, B., Achen, M. G., Stacker, S. A., Tulchinsky, E., Gillespie, G. Y., and Gibo, D. M. (2001) VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme. Mol. Med. 7, 598-608 (Pubitemid 34175288)
18. White, J. D., Hewett, P. W., Kosuge, D., McCulloch, T., Enholm, B. C., Carmichael, J., and Murray, J. C. (2002) Vascular endothelial growth factor- D expression is an independent prognostic marker for survival in colorectal carcinoma. Cancer Res. 62, 1669-1675 (Pubitemid 34408487)
19. Jüttner, S., Wissmann, C., Jöns, T., Vieth, M., Hertel, J., Gretschel, S., Schlag, P. M., Kemmner, W., and Höcker, M. (2006) Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J. Clin. Oncol. 24, 228-240 (Pubitemid 46622052)
20. van Iterson, V., Leidenius, M., von Smitten, K., Bono, P., and Heikkilä, P. (2007) VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer. Am. J. Clin. Pathol. 128, 759-766 (Pubitemid 350133986)
21. Nakamura, Y., Yasuoka, H., Tsujimoto, M., Yang, Q., Imabun, S., Nakahara, M., Nakao, K., Nakamura, M., Mori, I., and Kakudo, K. (2003) Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. Clin. Cancer Res. 9, 716-721 (Pubitemid 36182605)
22. Stacker, S. A., Williams, R. A., and Achen, M. G. (2004) Lymphangiogenic growth factors as markers of tumor metastasis. APMIS 112, 539-549 (Pubitemid 39626059)
23. Achen, M. G., Mann, G. B., and Stacker, S. A. (2006) Targeting lymphangiogenesis to prevent tumour metastasis. Br. J. Cancer 94, 1355-1360 (Pubitemid 43772266)
24. Achen, M. G., and Stacker, S. A. (2008) Molecular control of lymphatic metastasis. Ann. N.Y. Acad. Sci. 1131, 225-234 (Pubitemid 351758517)
25. Moffat, B. A., Chen, M., Kariaapper, M. S., Hamstra, D. A., Hall, D. E., Stojanovska, J., Johnson, T. D., Blaivas, M., Kumar, M., Chenevert, T. L., Rehemtulla, A., and Ross, B. D. (2006) Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D. Clin. Cancer Res. 12, 1525-1532
26. Grau, S., Thorsteinsdottir, J., von Baumgarten, L., Winkler, F., Tonn, J. C., and Schichor, C. (2011) Bevacizumab can induce reactivity to VEGF-C and -D in human brain and tumour derived endothelial cells. J. Neurooncol. 104, 103-112
27. Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., Ferrara, N., Fyfe, G., Rogers, B., Ross, R., and Kabbinavar, F. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New Engl. J. Med. 350, 2335-2342 (Pubitemid 38702844)
28. Stacker, S. A., Stenvers, K., Caesar, C., Vitali, A., Domagala, T., Nice, E., Roufail, S., Simpson, R. J., Moritz, R., Karpanen, T., Alitalo, K., and Achen, M. G. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274, 32127-32136
29. McColl, B. K., Paavonen, K., Karnezis, T., Harris, N. C., Davydova, N., Rothacker, J., Nice, E. C., Harder, K. W., Roufail, S., Hibbs, M. L., Rogers, P. A., Alitalo, K., Stacker, S. A., and Achen, M. G. (2007) Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J. 21, 1088-1098 (Pubitemid 46495698)
30. McColl, B. K., Baldwin, M. E., Roufail, S., Freeman, C., Moritz, R. L., Simpson, R. J., Alitalo, K., Stacker, S. A., and Achen, M. G. (2003) Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J. Exp. Med. 198, 863-868 (Pubitemid 37152923)
31. Baldwin, M. E., Roufail, S., Halford, M. M., Alitalo, K., Stacker, S. A., and Achen, M. G. (2001) Multiple forms of mouse vascular endothelial growth factor-D are generated byRNAsplicing and proteolysis. J. Biol. Chem. 276, 44307-44314
32. Von Marschall, Z., Scholz, A., Stacker, S. A., Achen, M. G., Jackson, D. G., Alves, F., Schirner, M., Haberey, M., Thierauch, K. H., Wiedenmann, B., and Rosewicz, S. (2005) Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int. J. Oncol. 27, 669-679
33. Baldwin, M. E., Halford, M. M., Roufail, S., Williams, R. A., Hibbs, M. L., Grail, D., Kubo, H., Stacker, S. A., and Achen, M. G. (2005) Vascular endothelial growth factor d is dispensable for development of the lymphatic system. Mol. Cell. Biol. 25, 2441-2449 (Pubitemid 40354637)
34. Harris, N. C., Paavonen, K., Davydova, N., Roufail, S., Sato, T., Zhang, Y. F., Karnezis, T., Stacker, S. A., and Achen, M. G. (2011) Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer. FASEB J. 25, 2615-2625
35. Achen, M. G., Williams, R. A., Minekus, M. P., Thornton, G. E., Stenvers, K., Rogers, P. A., Lederman, F., Roufail, S., and Stacker, S. A. (2001) Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J. Pathol. 193, 147-154 (Pubitemid 32118124)
36. Leppänen, V. M., Jeltsch, M., Anisimov, A., Tvorogov, D., Aho, K., Kalkkinen, N., Toivanen, P., Ylä-Herttuala, S., Ballmer-Hofer, K., and Alitalo, K. (2011) Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood 117, 1507-1515
37. Nice, E. C., and Catimel, B. (1999) Instrumental biosensors: new perspectives for the analysis of biomolecular interactions. Bioessays 21, 339-352 (Pubitemid 29211960)
38. Baldwin, M. E., Catimel, B., Nice, E. C., Roufail, S., Hall, N. E., Stenvers, K. L., Karkkainen, M. J., Alitalo, K., Stacker, S. A., and Achen, M. G. (2001) The specificity of receptor binding by vascular endothelial growth factor- D is different in mouse and man. J. Biol. Chem. 276, 19166-19171
39. Nilsson, I., Bahram, F., Li, X., Gualandi, L., Koch, S., Jarvius, M., Söderberg, O., Anisimov, A., Kholová, I., Pytowski, B., Baldwin, M., Ylä-Herttuala, S., Alitalo, K., Kreuger, J., and Claesson-Welsh, L. (2010) VEGF receptor 2/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J. 29, 1377-1388
40. Kärpänen, T., Heckman, C. A., Keskitalo, S., Jeltsch, M., Ollila, H., Neufeld, G., Tamagnone, L., and Alitalo, K. (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 20, 1462-1472 (Pubitemid 44943854)
41. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92, 735-745 (Pubitemid 28155313)
42. Favier, B., Alam, A., Barron, P., Bonnin, J., Laboudie, P., Fons, P., Mandron, M., Herault, J. P., Neufeld, G., Savi, P., Herbert, J. M., and Bono, F. (2006) Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108, 1243-1250 (Pubitemid 44232021)
43. Kawasaki, T., Kitsukawa, T., Bekku, Y., Matsuda, Y., Sanbo, M., Yagi, T., and Fujisawa, H. (1999) A requirement for neuropilin-1 in embryonic vessel formation. Development 126, 4895-4902
44. Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K., and Eichmann, A. (2002) Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129, 4797-4806 (Pubitemid 35282411)
45. Ferrara, N. (2010) Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action. Mol. Biol. Cell 21, 687-690
46. Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., and Ferrara, N. (1996) The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271, 7788-7795 (Pubitemid 26111064)
47. Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26031-26037 (Pubitemid 23014012)
48. Dixelius, J., Makinen, T., Wirzenius, M., Karkkainen, M. J., Wernstedt, C., Alitalo, K., and Claesson-Welsh, L. (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J. Biol. Chem. 278, 40973-40979 (Pubitemid 37280919)
49. Partanen, T. A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S. A., Achen, M. G., and Alitalo, K. (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 14, 2087-2096
50. Rutanen, J., Leppänen, P., Tuomisto, T. T., Rissanen, T. T., Hiltunen, M. O., Vajanto, I., Niemi, M., Häkkinen, T., Karkola, K., Stacker, S. A., Achen, M. G., Alitalo, K., and Ylä-Herttuala, S. (2003) Vascular endothelial growth factor-D expression in human atherosclerotic lesions. Cardiovasc. Res. 59, 971-979 (Pubitemid 38366253)
51. Yin, X., Johns, S. C., Lawrence, R., Xu, D., Reddi, K., Bishop, J. R., Varner, J. A., and Fuster, M. M. (2011) Lymphatic endothelial heparan sulfate deficiency results in altered growth responses to vascular endothelial growth factor-C (VEGF-C). J. Biol. Chem. 286, 14952-14962
52. Keck, R. G., Berleau, L., Harris, R., and Keyt, B. A. (1997) Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF. Arch. Biochem. Biophys. 344, 103-113 (Pubitemid 27328102)
53. Shraga-Heled, N., Kessler, O., Prahst, C., Kroll, J., Augustin, H., and Neufeld, G. (2007) Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. FASEB J. 21, 915-926 (Pubitemid 46348264)
54. Oh, H., Takagi, H., Otani, A., Koyama, S., Kemmochi, S., Uemura, A., and Honda, Y. (2002) Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 99, 383-388 (Pubitemid 34060370)
55. Xu, Y., Yuan, L., Mak, J., Pardanaud, L., Caunt, M., Kasman, I., Larrivée, B., Del Toro, R., Suchting, S., Medvinsky, A., Silva, J., Yang, J., Thomas, J. L., Koch, A. W., Alitalo, K., Eichmann, A., and Bagri, A. (2010) Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J. Cell Biol. 188, 115-130
56. Pajusola, K., Aprelikova, O., Pelicci, G., Weich, H., Claesson-Welsh, L., and Alitalo, K. (1994) Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9, 3545-3555 (Pubitemid 24359392)